Ziqing “Leo” Qian, Ph.D. is co-founder and Vice President, Discovery Research at Entrada Therapeutics, a Boston-based biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular therapeutics. Dr. Qian co-invented Entrada’s Endosomal Escape Vehicle (EEV™) platform, which is applied to the design and development of intracellular delivery of otherwise impermeable biological cargos, including oligonucleotides, proteins, and peptides. Leo obtained his Ph.D. in Organic Chemistry from The Ohio State University and worked with his advisor Dehua Pei, PhD.
Hosted by the Ohio Postgraduate Entrepreneurial Network (OPEN) at the Keenan Center for Entrepreneurship. OPEN is a new integrated resource at the Keenan Center for Entrepreneurship dedicated to increasing the entrepreneurial capacity of graduate students and postdocs. Opportunities include speaker series, entrepreneurial skills building workshops, mentorship and networking.